558
I. Yavari et al.
LETTER
R2
R2
+
N
+
N
Cl–
N
Ph
C
R1
C
R1
R1
HN
Et3N
3
2
N
1
N+
_
N
HBr
–
–
Ar
CO2Et
EtO2C
CO2Et
8
7
6
R2HN
R2N
Ph
Ph
1
imine–enamine
tautomerism
R1
R
N
N
[1,3]-H-shift
4
N
N
N
N
– HCl
Ar
Ar
EtO2C
EtO2C
9
10
Scheme 1
(7) Katritzky, A. R.; Fan, W.-Q.; Greenhill, J. V. J. Org. Chem.
1991, 56, 1299.
(8) Gupta, M.; Paul, S.; Gupta, R. Eur. J. Med. Chem. 2011, 631.
(9) Deam, M. L. Synthesis 1981, 322.
(10) Reddy, G. S.; Kumar, P. A.; Anand, R. V.; Mukkanti, K.;
Reddy, P. P. Synlett 2009, 1463.
(11) Demydchuk, B. A.; Brovarets, V. S.; Chernega, A. N.;
Rusanov, E. B.; Drach, B. S. Synthesis 2006, 2323.
(12) Birkett, P. R.; Chapleo, C. B.; Mackenzie, G. Synthesis
1991, 822.
ticeable broadening, even at 110 °C, the highest
temperature investigated. Thus, the conformational race-
mization barriers for compounds 4 are expected to be
higher than 16 kcal/mol.
A mechanistic rationalization for the reaction is given in
Scheme 1. The initial event is the formation of nitrogen
ylide 6, which is attacked by alkyl isocyanide to afford the
diionic intermediate 7. This intermediate undergoes a nu-
cleophilic substitution reaction with hydrazonoyl chloride
3 to generate 8, which affords 9 by intramoleculare cy-
clization reaction. Intermediate 9 is converted into 4 by
imine–enamine tautomerism and [1,3]-H shift.
(13) Raboisson, P.; Norberg, B.; Casimir, J. R.; Bourguignon,
J.-J. Synlett 2002, 519.
(14) Zaleska, B.; Trzewik, B.; Grochowski, J.; Serda, P. Synthesis
2003, 2559.
(15) General Procedure for the Synthesis of Compound 4
To a suspension of 1 (1 mmol) and isocyanide 2 (1 mmol) in
CH2Cl2 (4 mL) was added Et3N (2 mmol) at r.t. After stirring
for 20 h at r.t., hydrazonoyl chloride 3 (1 mmol) was added
to the solution and stirred for 10 h. Subsequently, the solvent
was evaporated, and the crude product was washed with
EtOAc. The solid mixture was dissolved in CH2Cl2 (5 mL)
and washed with two 3 mL portions of H2O, then dried
(Na2SO4), and evaporated under reduced pressure.
Selected Spectroscopic Data for Compound 4a
Pale yellow powder, mp 148–150 °C, yield 0.34 g, 90%. IR
(KBr): nmax = 3419 (NH), 1658, 1548, 1442 cm–1. 1H NMR
(500 MHz, CDCl3): d = 1.08 (3 H, t, 3J = 7.1 Hz, Me), 1.21
(9 H, s, CMe3), 4.14–4.15 (2 H, m, CH2O), 6.91 (1 H, t,
3J = 7.4 Hz, CH), 7.25–7.30 (4 H, m, 4 CH), 7.35–7.38 (2 H,
m, 2 CH), 7.60–7.62 (2 H, d, 3J = 7.7 Hz, 2 CH), 7.79 (1 H,
t, 3J = 6.4 Hz, CH), 7.93 (1 H, t, 3J = 6.4 Hz, CH), 8.48 (1 H,
t, 3J = 8.1 Hz, CH), 8.73 (1 H, d, 3J = 6.4 Hz, CH), 8.85 (1 H,
d, 3J = 6.4 Hz, CH), 9.59 (1 H, br s, NH), 10.32 (1 H, br s,
NH) ppm. 13C NMR (125.7 MHz, CDCl3): d = 13.9 (Me),
29.9 (CMe3), 54.7 (C), 60.3 (CH2O), 105.4 (C), 113.8 (2
CH), 121.0 (2 CH), 124.9 (C), 126.9 (CH), 127.1 (CH),
128.5 (CH), 128.7 (2 CH), 128.9 (2 CH), 130.9 (C), 135.0
(C), 143.8 (CH), 147.2 (CH), 147.5 (C), 148.3 (CH), 153.2
(C), 164.2 (C=O) ppm. MS: m/z (%) = 442 (4) [M+], 411
(75), 355 (77), 290 (28), 77 (100). Anal. Calcd (%) for
C27H30N4O2 (442.24): C, 73.28; H, 6.83; N, 12.66. Found
(%): C, 72.84; H, 6.51; N, 12.92.
In summary, we report a tandem transformation involving
ethoxycarbonylpyridinium bromides, hydrazonoyl chlo-
rides, and alkyl isocyanides, which affords a new route to
the synthesis of functionalized ethyl 1-(alkylamino)-4-
aryl-2,3-dihydro-2-phenylpyrido[2,1-d][1,2,5]triazepine-
5-carboxylates. Due to the presence of transformable
functionalities in these products they are potentially valu-
able for further synthetic manipulations.
Supporting Information for this article is available online at
References and Notes
(1) Dewick, P. M. Medicinal Natural Products, 2nd ed.; John
Wiley and Sons: Chichester, 2002.
(2) Tietze, L. F.; Brasche, C.; Gericke, K. M. Domino Reactions
in Organic Synthesis; Wiley-VCH: Weinheim, 2006.
(3) Serratosa, F.; Xicart, J. Organic Chemistry in Action: The
Design of Organic Synthesis; Elsevier: New York, 1996.
(4) Smith, W. A.; Bochkov, A. F.; Caple, R. Organic Synthesis:
The Science behind the Art; RSC: Cambridge / U.K., 1998.
(5) Basile, A. S.; Gammal, S. H.; Jones, E. A.; Skolnick, P.
J. Neurochem. 1989, 53, 1057.
(6) Bellantuono, C.; Reggi, G.; Tognoni, G.; Grattini, S. Drugs
1980, 19, 195.
(16) Gasparrini, F.; Lunnazi, L.; Misiti, D.; Villani, C. Acc.
Chem. Res. 1995, 28, 163.
Synlett 2012, 23, 557–558
© Thieme Stuttgart · New York